Keywords: roche, mabthera, filed, europe, ra, drug, swiss

Roche's MabThera filed in Europe as an RA drug

Article | 12 September 2005

Print This

Swiss drugmaker Roche has filed the first rheumatoid arthritis indication for its well-established cancer drug MabThera (rituximab) in Europe.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in